Researchers have identified inducible HIV reservoirs in various tissue models, including tonsillar, intestinal, and cervical tissue. These reservoirs are associated with HIV latency. The reservoir cells may become susceptible to a treatment, possibly Rituximab, after viral reactivation, as indicated by the expression of a specific marker.